Amarin Corp Plc (AMRN)

[Relic]

Thanks for posting.
This leads me to believe that infringement will be a win for Amarin due to it will have to be taken for the life of the patients. IMO

So if they lose that then the next step is obviousness. This is a little grey in my mind. It had to be obvious before 2016 that what? It lowers trigs only and if so would not the jelis study help confirm that?

Also can they win one side and enter the market or does it have to be both?

Thanks for answering in advance..

I’m an engineer not a lawyer or doc..